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Abstract
Antibiotic resistant infections are responsible for approximately 23,000 deaths every year
in the United States alone. The formation of bacterial biofilms makes resistant bacteria
difficult to eliminate completely using chemical treatment. Therefore, novel antimicrobial
compounds such as amphiphiles are essential to slow or stop the spread of resistant
bacteria. Several novel series of amphiphiles were synthesized, and discrete aspects of
their chemical structure were altered to investigate the relationship between structure and
antibacterial activity. Minimum inhibitory concentration (MIC) assays were used to
measure antibacterial activity against two Gram-negative and five Gram-positive
bacteria, and the most effective compounds were tested for biofilm disruption activity
against Pseudomonas aeruginosa using a Crystal Violet assay. For the tris-cationic ME,n,n; M-DMAP,n,n; M-IQ,n,n; and M-4PP,n,n series, twelve carbons per tail was the
ideal tail length for antibacterial activity, having MIC values as low as 4-8 µM against
Gram-negative species and 2-4 µM against Gram-positive species. The 12-carbon
derivatives also disrupted up to 70% of established P. aeruginosa biofilms at
concentrations comparable to tobramycin and benzalkonium chloride. Hofmeister
counterion substitution of one single-tailed and one double-tailed compound (M-1,1,18
and M-1,12,12, respectively) resulted in a notable 8-fold decrease in the MIC against P.
aeruginosa when the bromide counterion was replaced with chloride, and a 16-fold
decrease when the counterion was substituted with iodide. Finally, in order to determine
the effect of charge distribution in the head group, three bis-cationic (oX-n,n; mX-n,n;
and pX-n,n) and three tetra-cationic series (oX-(2,n)2; mX-(2,n)2; and pX-(2,n)2) of
double-tailed amphiphiles of varying tail lengths were synthesized and tested for their

ix

MIC values. For all three series of bis-cationic amphiphiles, as well as the mX-(2,n)2 and
pX-(2,n)2 series, the 12-carbon derivatives had the lowest MIC values. However, the oX(2,n)2 series had an ideal tail length of 8 carbons per tail. This further understanding of
the relationship between structure and function of antimicrobial amphiphiles can be used
to create more effective disinfectants and antibiotics. Continuing research into novel
antibacterial compounds and biofilm disrupting agents is essential to combat the growing
problem of antibiotic resistance.

x

Chapter 1. Introduction
1.1 Antibiotic- and Disinfectant-Resistant Bacteria
Bacteria that are resistant to commonly used antibiotics and disinfectants cause over 2
million illnesses and 23,000 deaths each year in the United States alone (CDC, 2013).
Several strains of resistant bacteria have emerged since the development of antibiotics.
Staphylococcus aureus is well-known for its ability to resist killing by antibiotics, and
Methicillin-resistant strains of S. aureus (MRSA) have been implicated in communityacquired infections after decades of being historically limited to a healthcare settings
(Chambers and DeLeo, 2009). Gram-negative bacteria can resist antibiotics by, among
other methods, altering the makeup and permeability of their outer membrane (Sawai et
al. 1979). Pseudomonas aeruginosa is a ubiquitous organism that has demonstrated
resistance to certain compounds partly due to its ability to enzymatically break down
these compounds after they enter the cell (Ali et al. 2015; Ma et al. 1998). Bacteria such
as Escherichia coli further resist centimide and other antibiotics by forming highly
resilient biofilms (Evans et al. 1990).
The development of resistance can be affected – and often accelerated – by human
activity. The overuse of antibiotics has been shown to lead to an increase in the incidence
of highly resistant organisms, particularly in hospitals (Dancer et al. 2009). Resistance to
some of the most effective antibiotics such as vancomycin and colistin, often used to treat
highly resistant infections, has also recently begun to emerge (Liu et al. 2016; Cardile et
al. 2015; Schrenk et al. 2015). Despite this increasing emergence of resistant infections,
antibiotics continue to be overprescribed in the United States and worldwide. The
consumption of antibiotic drugs increased 36% worldwide between 2000 and 2010,
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including increases in the prescription of last-resort antibiotics such as polymixins and
carbapenems (van Boeckel et al. 2014). Additionally, as many as 60% of the antibiotics
prescribed in United States intensive care units may not be the optimal agent for
eradication of the infection that is being treated, and the choice of treatment may be
incorrect in as many as 50% of cases (CDC, 2013; Luyt et al. 2014). In fact, in many
cases of infection, the causative agent is not positively identified at all (Bartlett et al.
2013), increasing the risk of inappropriate therapy contributing to the development of
resistance.
The majority of antibiotics sold in the United States, however, are used in agriculture
rather than in medicine in order to increase the growth and yield of domesticated animals
(Bartlett et al. 2013). The first case of plasmid-mediated resistance to the last-resort
antibiotic, colistin, carried on the mcr-1 gene, was traced back to the antibiotic’s use in
Chinese pig farms as a growth promoting treatment (Liu et al. 2016). These resistant
bacteria can reach consumers through animal products such as meat (Bartlett et al. 2013),
but can also be dispersed through secretion in urine and stool into groundwater and
fertilizer (Bartlett et al. 2013; CDC 2013). The same gene has been found in multiple
pathogenic bacteria such as Klebsiella pneumoniae (Nicolet et al. 2016) and E. coli
(Poirel et al. 2016). The dispersal of resistance genes between different species and even
genera or families leaves some pathogens unable to be treated with any known antibiotic.
The widespread and inappropriate use of antibiotics has led to an increase the demand
for novel antimicrobial compounds, particularly in hospital settings where resistant
infections can spread rapidly within immunocompromised populations. These healthcareassociated, or nosocomial infections, are often associated with invasive medical devices
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such as ventilators and catheters, and can be extremely difficult to treat due to several
bacterial resistance genes and virulence factors that decrease susceptibility to common
antibacterial agents (CDC, 2014).
1.2 Biofilms and Transmission of Resistant Bacteria – Implications for Nosocomial
Infection
Many diverse virulence factors may contribute to the resistance of pathogenic
bacteria to eradication by standard antimicrobials, but one that is particularly significant
to the spread of infections within hospitals is the formation of biofilms. A biofilm is a
collection of bacterial cells that have adhered irreversibly to a surface within a
heterogeneous extracellular polysaccharide matrix (Figure 1), which may compose as
much as 90% of the organic material of the biofilm. Although the physical characteristics
of the biofilm itself are highly variable, bacteria living within a biofilm tend to have a
decreased metabolic rate, as well as
increased resistance to antibacterial
compounds and the host immune
response (Donlan, 2002; Pawar et al.
2015). In addition, bacteria within
biofilms have also been shown to
acquire new resistance at a faster
rate than planktonic cells (Gillings et
al. 2009).

Figure 1. Scanning electron microscope image of
Staphylococcus aureus biofilm. Bacteria are surrounded by a
web-like extracellular matrix which protects them from
desiccation and chemical stressors. (Photo from the CDC Public
Health Image Library)

Biofilm formation begins when bacteria attach at first reversibly, and later
irreversibly, to a surface. At this stage, characteristics of the surface itself have significant
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influence on the rate of biofilm development, with rougher and more hydrophobic
materials generally fostering more rapid growth (Fletcher et al. 1979; Quirynen et al.
2000). Characteristics such as the presence of fimbriae (Rosenberg et al. 1982) or flagella
(Korber et al. 1989) also affect the initial attachment of bacteria to surfaces during
biofilm formation. Irreversibly attached cells form highly hydrated extracellular
polysaccharides, forming a heterogeneous matrix that includes filter-like channels which
transport nutrients throughout the biofilm (Lewandowski, 2000).
Established biofilms are difficult to remove using established chemical cleaning
protocols, often requiring extensive physical means of dispersal or harsh chemical
sterilization for complete removal (Vickery et al. 2004, 2012; O’Donnell et al. 2005).
Failure to completely remove these biofilms from hospital equipment such as catheters
can contribute to nosocomial infection by providing a route of infection to an
opportunistic pathogen. Cancer patients, for example, are particularly susceptible to
Staphylococcus infection through semi-permanent catheters such as peripherally inserted
central catheter (PICC) lines (Schrenk et al. 2015). Endoscopes serve as a major route of
nosocomial infection due to biofilm adherence; P. aeruginosa is often transmitted
between patients following incomplete cleaning of endoscopes between procedures.
However, although human error may contribute to a large portion of infection cases, even
strict compliance with cleaning protocol has been found to result in roughly a 2%
bacterial contamination rate in endoscopes deemed ready for use in patients (Vickery et
al. 2004). Therefore, current decontamination procedures are unable to completely
eradicate all biofilms or prevent transmission of infection between patients, even without
the addition of human error.
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P. aeruginosa and S. aureus, two opportunistic pathogens with high affinity for
biofilm formation, are also associated with additional complications following surgery.
Bacteria with higher capacity for biofilm formation tend to be associated with longer
recovery time and more complications following endoscopic surgical procedures
(Bendouah et al. 2006). S. aureus has also been implicated in cases of septic arthritis and
graft failure following ligament reconstruction surgery, as well as surgical site and bone
infections (Hiller et al. 2015; Wright and Nair, 2010; Humphreys et al. 2016). It is
important to note, however, that S. aureus and even P. aeruginosa have been observed as
part of the normal skin and nasal flora in healthy individuals, suggesting that other factors
influence virulence in addition to high affinity for biofilm formation (Al-Shemari et al.
2007).
P. aeruginosa is a prominent pathogen in hospital settings, and is responsible for
most cases of hospital-associated pneumonia (Brewer et al. 1996, Richards et al. 1999).
Pneumonia, along with
surgical site infection, is one
of the leading causes of

Other
118,500

morbidity and mortality
associated with nosocomial

Pneumonia
157,500

Surgical site
infections
157,500

GI infection
123,100

infection (CDC, 2014; Figure
UTIs
93,300

2). Additionally, P.
aeruginosa is highly resistant
to many disinfectant
compounds largely due to its

Bloodstream
Infections
71,900

Figure 2. Type distribution of reported nosocomial infections in the
United States (CDC, 2014).
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production of efflux pumps and β-lactamases (Li et al. 1994). Contamination of hospital
equipment such as ventilators and endoscopes can increase hospital-associated morbidity
and mortality by fostering the spread of bacteria between patients, causing infections
such as ventilator-associated pneumonia (VAP; Brewer et al. 1996).
Another prominent cause of nosocomial infection is Escherichia coli, which,
along with P. aeruginosa and Enterococcus species such as E. faecalis and E. faecium, is
one of the most common causes of bloodstream infections (Peleg, 2010, Olawale et al.
2011). E. coli is also the most common Gram-negative species implicated in urinary tract
infections associated with urethral catheters (Hidron et al. 2008), and uropathogenic
strains possess a variety of virulence factors aiding in persistence and infection, including
several associated with biofilm formation (Jacobsen et al. 2008).
Streptococcus agalactiae, also commonly known as Group B streptococcus, is
associated with severe meningitis in newborns, with onset possible as early as within one
week of birth, or as late as 3 months of age (Guiltbert et al. 2010). Although nosocomial
transmission has been mostly attributed to limited contamination by medical workers,
rare outbreaks have occurred where no common health care workers could be identified,
and were linked to environmental reservoirs within the neonatal intensive care unit
(MacFarguhar et al. 2010).
1.3 Antibacterial Development
Although the demand for antibiotic drugs is high, mof the world’s most prominent
scientific funding agencies allocate very little grant money to antibiotic discovery and
development (Speck, 2013). Funding institutions in the United Kingdom, for example,
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allocate only approximately 3.9% of total funds to antimicrobial resistance research
(Head et al. 2013). In the United States, the NIH allocated slightly over 1% of its budget
to antimicrobial resistance research, less than a tenth of what was allocated to
biotechnology and a seventh of what was allocated to research into aging (NIH, 2016).
Additionally, the development of antibiotics with novel targets and mechanisms
has slowed considerably. Two truly novel antibiotic classes with new microbial targets –
daptomycin and linezolid – have been introduced in the past decade (IDSA, 2010; 2011).
This is due in large part financial limitations, as research into antibiotics – which are
relatively cheap and most often used short-term – is not viewed as economically
profitable for pharmaceutical companies when compared to research into other drugs for
chronic health conditions (Piddock, 2012; Bartlett et al. 2013). Additionally, regulatory
barriers prevent the rapid delivery of novel drugs to market. Implementation of new drugs
can take up to 2 decades from drug discovery to use in the general public (Figure 3). This
is in part because human trials comparing the efficacy of new compounds to a placebo
are often considered unethical, and so studies must rely on comparisons to existing
antibiotics, necessitating large sample sizes and therefore high cost (Wright and Nair,
2014).

Figure 3. Timeline of novel drug discovery and development. Novel drug development can take up to
2 decades to complete, and involve proving safety and efficacy in humans before reaching the
majority of patients in need.
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One promising area of study is in the activity of antimicrobial peptides (AMPs),
which are short, positively charged, amphiphilic amino acid chains produced by a wide
array of organisms as part of the innate immune response (Jenssen et al. 2006). These
peptides have broad-spectrum antibacterial activity, affecting the bacterial cytoplasmic
membrane and causing depolarization and cell lysis (Hancock and Rozek, 2002). The
bactericidal activity of these peptides relies on both the charge of the molecule and
hydrophobic interactions for insertion into the membrane (Dathe and Wieprecht, 1999).
Many bacteria remain sensitive to killing by AMPs despite frequent exposure to these
peptides, likely due to the fact that many mutations conferring resistance to AMPs require
a high metabolic cost (Nizet, 2006). Despite the broad spectrum of efficacy of AMPs, the
widespread implementation of AMPs in a clinical setting is limited by the high cost of
large-scale AMP production (Marr et al. 2006; Findlay et al. 2010). The development of
wholly synthetic AMPs provides a potential way to circumvent the high cost of AMP
production, and amphiphilic AMP mimics lacking natural amino acids still have broadspectrum antibacterial activity against both Gram-negative and Gram-positive organisms
(Mowery et al. 2007; Scott et al. 2008). Quaternary ammonium compounds are simple
amphiphilic mimics of AMPs that are easier to produce, but still retain broad-spectrum
antibacterial and anti-biofilm activity (Jennings et al. 2014).
1.4 Amphiphiles
Amphiphiles are compounds that possess both a hydrophobic and a hydrophilic
portion on a single molecule (LaDow et al. 2011; Figure 4). The hydrophilic portion of
the molecule is charged, and cationic (positively-charged) amphiphiles have been the
focus of study for purposes of biofilm disruption due to the potential for interference with
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the negatively charged extracellular

Hydrophilic

Hydrophobic

matrix produced by bacteria (Jennings
et al. 2014). Such interactions would
likely be species-independent and
broad-spectrum, allowing for a wide

Figure 4. Generic amphiphile structure, including the
hydrophilic head group (blue) and the hydrophobic
hydrocarbon tail group (red).

range of uses. Additionally the sheer
number of possible structures available would promote a higher diversity of effective
compounds to protect against the development of resistance resulting from the overuse of
any single compound.
The antibacterial activity of these types of compounds was first noted in 1935,
and they are still commonly used as disinfecting agents and detergents (Gerhard, 1935).
Amphiphiles have a wide array of possible structures, and some of the most promising
are quaternary ammonium compounds (Forman et al, 2016). Ample research exists
investigating the relationship between amphiphile structure and antibacterial activity
(LaDow et al. 2011; Marafino et al. 2015; Song et al. 2011; Palermo et al. 2009).
Previous studies have provided information about the effect of cationic head group
substitution and hydrophobic hydrocarbon chain length on the minimum inhibitory
concentration (MIC) of certain compounds on bacteria including P. aeruginosa and S.
aureus. Structural changes such as hydrocarbon tail length variation, tail symmetry, and
changes in the charge and structure of the hydrophilic region have been studied for their
effects on antibacterial activity (Marafino et al. 2015; LaDow et al. 2011; Paniak et al.
2014). In particular, the size of the hydrophobic region appear to be the strongest
indicator of membrane permeability and antibacterial activity, with changes in the charge
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and size of the hydrophilic region having less of an effect on the effectiveness of QACs
(Paniak et al. 2014).
Cationic amphiphiles interact strongly with the negatively charged phospholipids
that make up 20-25% of the membrane (Glukov et al. 2005). The primary mechanism of
action of these amphiphiles is disruption of the bacterial cell membrane, leading to
disruption of transport proteins and proton motive force, cell lysis and death (Hoque et al.
2012; Thiyagarajan et al. 2014; Ladow et al. 2011). As the lipid membrane is ubiquitous
and energetically costly to repair, QACs offer broad-spectrum efficacy and little potential
for the development of total resistance (Vudumula et al. 2012). This is particularly
promising for the treatment of Gram-negative pathogens, whose additional outer
membrane can decrease their susceptibility to several antibiotics unable to pass through
the additional barrier (Bola et al. 2011).
The biofilm disruption capabilities of amphiphilic compounds have also been the
focus of a large amount of research. Previous work has suggested that amphiphilic
polymers containing amide side chains are not only effective bactericidal agents against
antibiotic-resistant strains of bacteria such as MRSA and vancomycin-resistant
Enterococcus faecium (VRE), but were also more effective at disrupting both nonresistant and multidrug-resistant Acinetobacter baumanii biofilms than established
antibiotics such as erythromycin, tobramycin, and colistin (Uppu et al. 2016).
Amphiphiles with different structures, including QACs, have also exhibited biofilmdisruption activity. The likely mechanism of action of biofilm disruption by these
compounds involves biofilm dispersal by electrostatic interactions which allow the
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compounds to lyse the planktonic cells released from the biofilm, leading to biofilm
disruption due to the death of bacterial cells (Jennings et al. 2014).

1.5 Amphiphiles Used in the Current Study
Head group substitution and hydrocarbon tail length variation
Four series of double tailed triscationic amphiphiles were
synthesized by the Caran lab (James
Madison University). For each
series, the amphiphiles consisted of a
mesitylene core (M) with three

M-E,n,n series
n = 8,10,12,14,16

M-DMAP,n,n series
n = 10,12,14,16

attached positively charged head
groups. Two of these head groups
were dimethylalkylammonium
groups with attached hydrocarbon
tails. The third head group was either
dimethylethanolammonium for the
M-E,n,n series,
dimethylaminopyridinium for the MDMAP,n,n series, isoquinolinium for

M-IQ,n,n series
n = 10,12

M-4PP,n,n series
n = 10,12,14

Figure 5. Structure of amphiphiles. M represents the Mesitylene
core; n represents the number of carbons in each symmetrical
hydrocarbon tail. E = dimethylethanolammonium, DMAP =
dimethylaminopryidinium, IQ = isoquinolinium, and 4PP = 4propanol pyridinium.

the M-IQ,n,n series, and 4-propanol pyridinium for the M-4PP,n,n series. The
hydrocarbon tails were linear and symmetrical, and consisted of 8-16 carbons each for the
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M-E,n,n series, 10-16 carbons each for the M-DMAP,n,n series, 10-12 carbons each for
the M-IQ series, and 10-14 carbons each for the M-4PP,n,n seres (Figure 5).

Counterion exchange
Two tris-cationic amphiphiles were synthesized by the Caran lab in order to determine
the effects of counterion substitution on antibacterial activity. One single-tailed
compound (M-1,1,18) and one double-tailed compound (M-1,12,12), which have both
been previously studied (Marafino et al 2015), were used. Both compounds consisted of
three positively charged dimethylalkylammonium residues attached to a mesitylene core,
with a linear 18-carbon chain attached to one of these groups in M-1,1,18, and a linear
12-carbon chain attached to each of two of the groups in M-1,12,12 (Figure 6). The
standard bromide counterions
were substituted with
carbonate, acetate, nitrate,
chloride, or iodide for M1,1,18, and substituted with
M-1,1,n series +
Hofmeister
counterion
n = 18

M-1,n,n series +
Hofmeister
counterion
n = 12

Figure 6. Structure of amphiphiles. M represents the Mesitylene core;
n represents the number of carbons in each symmetrical hydrocarbon
tail. X- represents the Hofmeister counterion in solution with the
amphiphile (bromide, carbonate, acetate, nitrate, chloride, or iodide).

acetate, chloride, or iodide for
M-1,12,12. The structure of the
amphiphiles themselves was
not changed with these
substitutions.

Spacer variation and hydrocarbon tail length variation
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Three series of bis-cationic and three series of tetra-cationic double-tailed amphiphiles
were synthesized by the Caran lab in order to determine the effects of varied placement
of the headgroups and tails on the central mesitylene ring. The bis-cationic oX-, mX-, and
pX-n,n series consisted of two dimethylalkylammonium residues attached to the central
ring in either the ortho (oX-n,n series), meta (mX-n,n series) or para orientation (pX,n,n
series). One linear hydrocarbon chain was attached to each of the two
dimethylalkylammonium groups, and contained 8-14 carbons for the oX-n,n series, 8-12
carbons for the mX-n,n series, and 8-16 carbons for the pX-n,n series (Figure 7).

oX-n,n series
n = 8,10,12,14

mX-n,n series
n = 8,10,12

pX-n,n series
n = 8,10,12,14,16

Figure 7. Structure of bis-cationic amphiphiles. n represents the number of
carbons in each symmetrical hydrocarbon tail. oX = ortho-orientation; mX
= meta-orientation; pX = para-orientation.

The tetra-cationic amphiphile series were structured similarly, however two
dimethylalkylammonium head groups were attached to each of the same positions on the
central ring, connected by a 2-carbon linker. The linear hydrocarbon tail connected to the
head group in each of the tetra-cationic series contained 8-12 carbons for the oX-, mX-,
and pX-(2,n)2 series (Figure 8).

14

oX-(2,n)2 series
n = 10,12,14

mX-(2,n)2 series
n = 10,12,14

pX-(2,n)2 series
n = 10,12,14

Figure 8. Structure of tetra-cationic amphiphiles. n represents the number of carbons in
each symmetrical hydrocarbon tail. oX = ortho-orientation; mX = meta-orientation; pX =
para-orientation.

Additional compounds
One series of amphiphiles was synthesized by the Caran lab including 6 total
dimethylalkylammonium head groups and three linear hydrocarbon tails of 8, 10, or 12
carbons in length (Figure 9). The hexa-cationic M-(2,n)3 series was tested for its
antibacterial activity with tail length variation.
The final compound synthesized by the Caran lab was 10-14-AO, a mono-cationic
fluorescent compound derived from acridine orange that included a single 14-carbon tail
(Figure 10).
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Figure 10. Structure of the fluorescent
acridine orange derivative, 10-14-AO.

Figure 9. Structure of the 6-headed,
triple-tailed M-(2,n)3 series. n
represents the number of carbons per
tail (8,10,12).
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Chapter 2: The effect of tail length variation and head group substitution on
minimum inhibitory concentration and biofilm disruption.
2.1 Introduction.
Bacteria that are resistant to commonly used antibiotics and disinfectants cause
over 2 million illnesses and 23,000 deaths each year in the United States alone (CDC,
2013). The development of resistance can be affected – and often accelerated – by human
activity. The overuse of frequently used antibiotics has led to an increase in the incidence
of highly resistant organisms, particularly in hospitals (Dancer et al. 2009). Resistance to
powerful antibiotics such as vancomycin and colistin, often used to treat highly resistant
infections, has also recently emerged (Liu et al. 2016; Cardile et al. 2015; Schrenk et al.
2015).
The accelerated development of resistance in ubiquitous organisms has
contributed to the increased prevalence of nosocomial infections, which spread rapidly
within immunocompromised populations often found in hospitals and nursing homes
(Johnston and Bryce, 2009). Nosocomial infections such as pneumonia, bloodstream
infections, and urinary tract infections are responsible for approximately 75,000 patient
deaths every year (Magill et al. 2014) and place a significant economic burden on the
United States healthcare system (CDC, 2013). Gram-negative bacteria can further resist
antibiotics by altering the makeup and permeability of their outer membrane in addition
to having other adaptations for resistance (Sawai et al. 1979). Pseudomonas aeruginosa is
a ubiquitous organism that has demonstrated resistance to certain compounds partly due
to its ability to enzymatically break down these compounds after they enter the cell (Ali
et al. 2015; Ma et al. 1998). Bacteria such as Escherichia coli resist centimide and other
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antibiotics by forming biofilms (Evans et al. 1990). The development of novel
antibacterial compounds is essential to curb the spread of resistant infections between
patients and to reduce hospital-associated morbidity and mortality.
Amphiphiles are a diverse class of compounds with well-documented
antibacterial effects (Marafino et al. 2015; Ladow et al. 2011; Goswami et al. 2015;
Thiyagarajan et al. 2014; Song et al. 2011). The antibacterial activity of these compounds
was first noted in 1935, and they are still commonly used as disinfecting agents and
detergents (Gerhard, 1935). Amphiphiles have a wide array of possible structures, and
some of the most promising are quaternary ammonium compounds, which are molecules
containing positively charged nitrogen residues (Forman et al. 2016). In addition to the
charged hydrophilic head group, amphiphiles also contain a hydrophobic portion, usually
consisting of one or more hydrocarbon tails. Structural changes such as hydrocarbon tail
length variation, symmetry, and changes in the charge and structure of the hydrophilic
region have been studied for their effects on antibacterial activity (Marafino et al. 2015;
Ladow et al. 2011; Paniak et al. 2014). In particular, the size of the hydrophobic region
appear to be the strongest indicator of membrane penetration and antibacterial activity,
with changes in the charge and size of the hydrophilic region having less of an effect on
the effectiveness of QACs (Paniak et al. 2014). Increased understanding of the effects of
amphiphile structure on bactericidal activity is essential for the development of more
effective antibacterial compounds.
Four novel series of amphiphiles were synthesized, and the antibacterial effect of
changes in head group structure and tail length was determined. All four series consisted
of three cationic head groups connected to a mesitylene core. For each series, two of the
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head groups were dimethylalkylammonium groups, each connected to a linear
hydrocarbon tail. The hydrocarbon tails were symmetrical and ranged in length from 8-16
carbons for the M-E series, 10-16 carbons for the M-DMAP series, 10-12 carbons for the
M-IQ series, and 10-14 carbons for the M-4PP series. The third head groups were an
dimethylethanolammonium (M-E series), dimethylaminopyridinium (M-DMAP series),
isoquinolinium (M-IQ series), or 4-propanol pyridinium (M-4PP series; Figure 5).
2.2 Results and Discussion.
Critical Aggregation Concentration
The critical aggregation concentration (CAC) refers to the concentration at which
the molecules aggregate in solution. Below the CAC, the amphiphile tends to behave as a
monomer, while above the CAC, the amphiphile behaves as a micelle. The CAC was
determined for the 10-16 carbon chain length derivatives of the M-E series. Consistent
with previous studies of amphiphiles with similar structures (Marafino et al. 2015), the
CAC decreases with increasing tail lengths, suggesting that a longer pair of hydrophobic
hydrocarbon tails encourages aggregation into micelles at lower concentrations (Figure
11).
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Figure 11. Critical aggregation concentration for the 10, 12, 14, and 16 carbon
tail length derivatives of the M-E,n,n series.

Information about the CAC can also be used to determine more about the
mechanism of action of these compounds, namely whether they act as monomers to exert
a bacteriocidal effect, or if they act more similarly to detergents (as micelles). Because
the MIC of all of the M-E series derivatives tested was below the CAC (Table 1, Table
2), it is likely that these compounds are acting as monomers at bactericidal
concentrations, and do not have a mechanism of action similar to detergents. This
supports previous research on similar compounds, where tris-cationic double-tailed
amphiphiles with trimethylammonium or pyridinium head groups also had MICs that fell
far below their respective CAC values (Marafino et al. 2015).
Minimum Inhibitory Concentration
The minimum inhibitory concentration (MIC) was determined for two Gramnegative bacterial species (P. aeruginosa and E. coli) and five Gram-positive species (S.
aureus, E. faecalis, S. agalactiae, B. subtilis, and B. anthracis; Table 1, Figure 12). For
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all series (with only one exception) the MIC was lowest at a tail length of 12 carbons per
tail. Above or below this optimal tail length, the MIC increased. This trend was observed
for both Gram-negative and all Gram-positive bacteria tested. A similar trend was
observed for all head group substitutions, with 12 carbons being the ideal tail length for
structures with an dimethylethanolammonium, dimethylaminopyridinium,
isoquinolinium, or 4-propanol pyridinium head group (Figure 12).
The 12-carbon compound M-E,12,12 had MIC values ranging from 2-4 μM for
Gram-positive bacteria, and 4-8 μM for Gram-negative bacteria. M-DMAP,12,12 had an
MIC of 8 μM for both Gram-negative species, and MIC values ranging from 2-8 μM for
Gram-positive species. MIC values for M-4PP,12,12 ranged from 2-4 μM for all bacteria
tested, and those for M-IQ,12,12 ranged from 4-8 μM. Both M-4PP,12,12 and MIQ,12,12 were able to effectively inhibit the growth of P. aeruginosa at concentrations as
low as 4 μM, a concentration comparable to the antibiotic tobramycin, an aminoglycoside
widely used to treat chronic P. aeruginosa infection (Shawar et al. 1999).
The trends observed for these compounds are consistent with previous research on
structurally similar amphiphiles. Derivatives with two 12-carbon chains in the tail region
have previously been reported to have lower MIC values than those with longer or shorter
tails (Marafino et al. 2015).
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Table 1. MIC values for all compounds, benzalkonium chloride (BZK), and tobramycin. Values were
confirmed with 2-3 independent experiments. X = head group (E = dimethylethanolammonium; DMAP =
dimethylaminopyridinium; IQ = isoquinolinium; 4PP = 4-propanol pyridinium) and n = the number of
carbons per tail. G+ = Gram-positive and G- = Gram-negative.
Compound
(M-X,n,n)
M-E,8,8
M-E,10,10
M-E,12,12
M-E,14,14
M-E,16,16
M-DMAP,10,10
M-DMAP,12,12
M-DMAP,14,14
M-DMAP,16,16

M-4PP,10,10
M-4PP,12,12
M-4PP,14,14
M-IQ,10,10
M-IQ,12,12
BZK
Tobramycin

P. aeruginosa
(G-)

E. coli
(G-)

>250
250
8
125
125
63
8
16
250
8
4
31
125
4
8
4

>250
125
4
8
63
63
8
16
31
4
2
16
8
8
31

Minimum Inhibitory Concentration (μM)
E. faecalis S. aureus B. subtilis S. agalactiae
(G+)
(G+)
(G+)
(G+)

63
4
2
4
63
8
2
4
8
4
4
4
4
4
8

250
125
4
8
63
63
4
4
16
4
2
16
8
4
16

250
16
4
8
>250
16
8
8
16
2
2
4
8
4

B. anthracis
(G+)

125
4
2
4
>250
8
2
4
8
2
4
4
4
4
2

63
4
2
8
>250
4
2
4
8
2
2
4
8
4

Replacing the hydrophilic dimethylethanolammonium residue with
dimethylaminopyridinium, isoquinolinium, or 4-propanol pyridinium did not
significantly change the trend in MIC. Other structurally similar 12-carbon derivatives
with different head groups (trimethylammonium and pyridiunium) studied previously
have had comparable antibacterial activity, further illustrating the effect of tail length on
the efficacy of these double-tailed amphiphiles (Marafino et al. 2015). Taken together,
these data suggest that substitution with equally charged head groups of comparable size
does not have a considerable effect on antibacterial activity, and that tail length has a
much larger effect on the ability of these compounds to inhibit bacterial growth.
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Structurally, these compounds are similar to benzalkonium chloride (BZK), a
synthetic quaternary ammonium biocide with broad-spectrum antibacterial activity
(Carson et al. 2008; Fazlara and Ekhtelat, 2012). Interestingly, all of the 12-carbon
derivatives, as well as some 10- and 14-carbon derivatives tested have greater
antibacterial activity than BZK against Gram-negative and Gram-positive species
(Fazlara and Ekhtelat, 2012).
All four series of tris-cationic, double-tailed amphiphiles presented in this study
follow the previously illustrated trend suggesting a strong relationship between
hydrocarbon tail length and antibacterial activity. Amphiphiles with 12 carbons in each
symmetrical tail were the most effective at inhibiting all species of bacteria tested,
supporting the findings of previous work (Marafino et al. 2015).
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Figure 12. The effect of tail length on antibacterial activity of the M-E,n,n; M-DMAP,n,n; M-IQ,n,n;,
and M-4PP,n,n series. G- = Gram-negative and G+ = Gram-positive. Bacterial strain names are
indicated.
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Biofilm disruption.
Established P. aeruginosa biofilms were exposed to two-fold dilutions ME,12,12; M-DMAP,12,12; M-IQ,12,12; and M-4PP,12,12 . The percentage of biofilm
disruption increased in a concentration-dependent manner from 2-63 µM for all
amphiphiles tested, but at concentrations above 63 µM, increasing the compound
concentration did not increase biofilm disruption. The amphiphiles tested disrupted a
maximum of approximately 65% of established biofilm, with the exception of M4PP,12,12, which had a maximum disruption of approximately 40% (Figure 13).
This disruption activity was compared to that of BZK and the aminoglycoside
tobramycin. At similar concentrations, tobramycin disrupted approximately 66% of
established biofilm, while BZK disrupted approximately 35-40% (Figure 13).
Bacterial biofilms are commonly associated with greatly increased resistance to
biocides due to the formation of a protective extracellular matrix and reduced metabolic
rate of biofilm-associated cells (van der Veen and Abee, 2010; Costerton et al. 1999).
Due to this increased resistance compared to planktonic cells, it is unsurprising that the
concentration of biocide necessary to attain maximum biofilm disruption is several
dilutions higher than the MIC, which was determined against planktonic cells.
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Figure 13. P. aeruginosa biofilm disruption by (A) M-E,12,12; (B) M-DMAP,12,12;
(C) M-4PP,12,12; (D) M-IQ,12,12; (E) tobramycin and (F) BZK. Error bars represent
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2.3 Conclusions.
These data further support the relationship between solubility and antibacterial
activity, suggesting that there is an ideal level of solubility that may maximize
bactericidal efficiency. Of particular note are the MIC values of M-E,12,12; MDMAP,12,12; M-4PP,12,12; and M-IQ,12,12. These compounds are effective at
inhibiting the growth of P. aeruginosa at concentrations as low as 4-8µM (Table 1). P.
aeruginosa is a prominent pathogen in hospital settings, and is responsible for most cases
of hospital-associated pneumonia (Brewer et al. 1996; Richards et al. 1999).
Additionally, P. aeruginosa is highly resistant to many disinfectant compounds due to its
semipermeable outer membrane and the production of efflux pumps and β-lactamases (Li
et al. 1994). Contamination of hospital equipment such as ventilators and endoscopes can
increase hospital-associated morbidity and mortality by fostering the spread of bacteria
between patients, causing infections such as ventilator-associated pneumonia (VAP;
Brewer et al. 1996). Four compounds mentioned effectively inhibit the growth of P.
aeruginosa at concentrations comparable to the MIC of tobramycin, an antibiotic used to
treat P. aeruginosa infection in cystic fibrosis patient (Oliver et al. 2000; Singh et al.
2000; Vidya et al. 2016). Given this, as well as the fact that the MIC values of the most
effective compounds were lower than those of the disinfectant, benzalkonium chloride,
these compounds may prove useful in a hospital setting as novel disinfectants to prevent
the spread of nosocomial infection due to P. aeruginosa. Because biofilm contributes to
the spread and pathogenesis of P. aeruginosa, he potential for synergistic interaction
between the compounds presented in this study and biofilm matrix-degrading enzymes
such as dispersin B warrants future study (Kaplan, 2010).
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Further research is needed to understand the mechanism of action of these
compounds against bacterial biofilms, as it is uncertain whether they are actively
interacting with the extracellular biofilm matrix or merely penetrating the matrix to target
the bacterial cells embedded in the biofilm. The solubility and hydrophobicity of the EPS
is highly variable, and it likely possesses localized hydrophilic and hydrophobic regions,
making it unclear to what extent these amphiphiles are able to interact with the matrix
effectively (Sutherland, 2001).
Given the increasing incidence of hospital acquired infection, particularly by
highly resistant strains of bacteria, the need for novel antibacterial compounds is
paramount, and understanding structure-function relationships of bactericidal molecules
is necessary for the development of more effective disinfectants. Several compounds
presented in this study show potential as novel disinfectants, either alone or in synergistic
combination with other disinfecting agents or antibiotics. It is likely that these
compounds behave similarly to other amphiphiles against planktonic cells by targeting
the bacterial membrane (Goswami et al. 2015; Thiyagarajan et al. 2014; Song et al.
2011). Gram-negative bacteria are particularly difficult to eradicate due to the presence of
an outer membrane serving as a selectively permeable barrier to chemical stressors (Bolla
et al. 2011). Membrane-permeabilizing agents, therefore, may lead to enhanced
susceptibility to antibiotics not normally able to bypass this barrier. The results presented
in this work provide information on the relationship between amphiphile structure and
function, and may lead to the development of novel disinfecting agents that could
decrease hospital-associated morbidity and mortality as a result of bacterial transmission.
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2.4 Methods
Colloidal properties
A conductivity probe was used to measure the critical aggregate concentration of
the amphiphile. The solution was heated to 37°C. The probe was mixed in the solution
and the measurements were collected. Ten percent of the solution was pipetted out and
replaced with nanopure water. The solution was mixed and the conductivity measurement
recorded. These steps were repeated for the entirety of the experiment.
Bacterial strains and growth conditions.
The two Gram-negative bacterial strains used were Escherichia coli ATCC®
25922™ and Pseudomonas aeruginosa ATCC® 27853™, and the five Gram-positive
bacterial strains used in this study were Staphylococcus aureus subsp. aureus ATCC®
29213™, Enterococcus faecalis ATCC® 29212™, Bacillus subtilis, B. anthracis Sterne,
and Streptococcus agalactiae J48 (Seifert et al. 2006). All strains were grown in 1x
Mueller-Hinton Broth at 37° C for 12–24 h. For the MIC studies, bacterial suspensions
were prepared by diluting overnight cultures to 5x106 CFU/mL in 2X Mueller-Hinton
Broth, so that when amphiphile solutions were added the final broth strength was 1X.
Minimum inhibitory concentration.
The methods used to determine the MIC were performed as previously described
and followed standards of the Clinical and Laboratory Standards Institute (Ladow et al.
2011; CLSI, 2012). Briefly, compounds were serially diluted in sterile deionized water
and 100µL of each dilution were added to the wells of a 96-well flat-bottomed microtiter
plate in triplicate. After adding 100µL of the bacterial cell suspension (5x106 CFU/mL),
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the plates were incubated at 37°C for 72 h. The MIC of the compound was defined as the
minimum concentration that resulted in visible inhibition of bacterial growth.
Biofilm disruption
Biofilm disruption was determined as previously described (O’Toole, 2011).
Briefly, 100µL of 5x106 CFU/mL P. aeruginosa suspended in Luria Broth (LB) were
added to a 96-well flat-bottomed microtiter plate. Plates were incubated at 37° C for 24 h
to allow the biofilm to form. Sterile dI H2O served as a negative control for biofilm
disruption, and 100µL of each dilution of the compounds were added in triplicate to the
remaining wells. Plates were incubated at 37° C for another 24 h, after which the plates
were emptied and rinsed with sterile dI water and allowed to dry. Wells were stained with
100µL crystal violet, rinsed with gently running water, and allowed to dry. Finally,
100µL of 95% ethanol was added to each well for 1 h. The ethanol-crystal violet solution
was transferred to a fresh 96-well microtiter plate, and the absorbance value at 570 nm
was determined.
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Chapter 3: The effect of Hoffmeister series counterion exchange on minimum
inhibitory concentration of single- and double-tailed amphiphiles.
3.1 Introduction.
Counterions accompany charged molecules in solution in order to maintain
electric neutrality. These counterions can have an effect on several aspects of the
interaction between molecules in solution, most notably on micellization of surfactants
(Naskar et al. 2012) . The self-assembly of amphiphiles in solution is a
thermodynamically driven process that can be affected by differences in the hydrocarbon
tail length and the charge and size of the hydrophilic head group. Ions in solution interact
with the head group, and thereby have an effect on the assembly of monomers into
micelles (Rosholm et al. 2010). These interactions are of particular interest to medicinal
chemistry and drug discovery, since variation of the counterion paired with antibacterial
compounds may affect antibacterial activity.
Of particular interest are counterions from the well-studied Hofmeister series
(Figure 14). The Hofmeister series was originally observed by Franz Hofmeister in 1888,
and was reported to be a series of salts ordered according to their ability to precipitate
proteins out of solution
(Hofmeister, 1888; Kunz
et al. 2004; Lo Nostro et
al. 2012). More recently,
ions in the Hofmeister
series have been
correlated with several

Figure 14. Selected counterions from the Hofmeister used in this study,
presented in order from strongly hydrated kosmotropes (left) to weakly
hydrated chaotropes (right).
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chemical properties of amphiphiles in solution (Rosholm et al. 2010), as well as having a
documented effect on the growth of both Gram-positive and negative bacteria including
S. aureus and P. aeruginosa (Lo Nostro et al. 2005).
Interestingly however, relatively little research has been done on the effects of
Hofmeister series counterion substitution on the antibacterial activity of amphiphiles and
similar membrane-active compounds. Therefore, the relationship between the known
properties of Hofmeister series counterion exchange and amphiphile activity remains
largely unknown.
It was hypothesized that changes in micelle formation and aggregation due to
counterion substitution could lead to a change in MIC correlated with the chemical
changes associated with the Hofmeister series. Therefore, one single-tailed amphiphile
(M-1,1,18) and one double-tailed amphiphile (M-1,12,12) were selected for counterion
substitution (Figure 6). These amphiphiles were selected due to their low MIC values
compared to other compounds with different hydrocarbon chain lengths in their
respective series (Marafino et al. 2015). Counterions from the Hofmeister series were
substituted for bromide (3Br-) without altering the structure of either amphiphile in order
to determine whether counterion exchange on its own was sufficient to cause changes in
MIC.
3.2 Results and Discussion.
Critical aggregation concentration
CAC, predictably, increased with increasing chaotropicity for single-tailed
derivatives paired with different counterions in the Hofmeister series. When paired in
solution with iodide, M-1,1,18 formed micelles at a minimum concentration
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approximately ten times lower than when paired with acetate, a more weakly hydrated
kosmotrope (CAC table).
Nitrogen-based cations such as those found in these amphiphiles have been categorized
previously as largely chaotropic. Chaotropes interact most strongly with other chaotropes
in solution, which may explain the decrease in CAC when M-1,1,18 was paired with
other more chaotropic Hofmeister ions in solution (Abezgauz et al. 2009).

Table 2. CAC values of M-1,1,18 paired with
six selected Hofmeister anions.

Counterion
(M-1,1,18 + X)
CO32C2H3O2ClBrNO3I-

CAC
(mM)
N/A
10.10
5.96
3.13
2.07
1.03

Minimum inhibitory concentration
Previously, all compounds tested in this study had bromide as the counterion;
however, the effects of counterion substitution with other Hofmeister series anions had
not been tested. Six Hofmeister anions (bromide, carbonate, acetate, nitrate, chloride, and
iodide) were selected for counterion exchange with the single-tailed compound, M-1,1,18
(Table 3). Substitution with carbonate, acetate, or nitrate resulted in slightly increased
MIC values, particularly against Gram-positive bacteria, suggesting that these
counterions may cause decreased bacteriocidal efficacy for this compound. Interestingly,
while acetate and carbonate are both more kosmotrophic than bromide in the Hofmeister
series, nitrate is more chaotrophic. It is likely that the change in antibacterial activity can

33
therefore not be attributed to the chemical attributes of the Hofmeister series alone when
these ions are paired with these antibacterial compounds.
Chloride and iodide were also investigated as possible counterions for these
amphiphiles. When paired with both of these anions, M-1,1,18 had much lower MIC
values compared to M-1,1,18 paired with the other anions studied. Most notably,
substitution with chloride and iodide resulted in a sixteen-fold and eight-fold decrease in
MIC compared to bromide for P. aeruginosa, respectively, and an eight-fold decrease in
MIC for S. aureus. While M-1,1,18 paired with bromide had an MIC of 125 µM against
P. aeruginosa, the same compound was able to inhibit the growth of P. aeruginosa at 8
µM when paired with chloride and at 16 µM when paired with iodide. Counterion
exchanged M-1,1,18 paired with chloride and iodide were, with very few exceptions,
more effective than M-1,1,18 paired with carbonate, acetate, or nitrate (Table 3).

Table 3. MIC values of M-1,1,18 paired with six selected Hofmeister series anions (X): bromide,
carbonate, acetate, nitrate, chloride, and iodide. Values were confirmed with 2-3 independent experiments.
G+=Gram-positive and G-=Gram-negative.
Counterion
(M-1,1,18 + X)

3 Br1.5 CO323 C2H3O23 NO33 Cl3 I-

P. aeruginosa
(G-)

E. coli
(G-)

125
250
250
250
8
16

16
31
63
63
16
8

Minimum Inhibitory Concentration (μM)
E. faecalis S. aureus B. subtilis S. agalactiae
(G+)
(G+)
(G+)
(G+)

4
31
16
16
8
16

16
31
63
31
2
2

4
16
31
16
2
16

B. anthracis
(G+)

2
4
4
4
4
4

4
31
31
31
2
8

Despite notable changes in MIC with counterion exchange, no clear trend
between Hofmeister series order and antibacterial activity was observed. The observed
increase in CAC with increasing chaotropicity was not an accurate predictor of
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antibacterial activity. It is possible that other unknown factors, independent of Hofmeister
series attributes, may contribute to antibacterial activity for these counterion exchanged
amphiphiles, especially since somewhat different trends were observed for Gramnegative versus Gram-positive species tested.
To determine whether similar trends existed with counterion exchange for doubletailed amphiphiles, the compound M-1,12,12 was paired with four different Hofmeister
series anions: bromide, acetate, chloride, and iodide. Very little difference in MIC was
observed for Gram-positive species, although M-1,12,12 paired with iodide did have
lower MIC values compared with the compound paired with bromide. A four-fold
decease in MIC was observed against P. aeruginosa for the chloride- and iodide-paired
compound compared to the compound with bromide serving as the counterion.
Interestingly, M-1,12,12 paired with acetate had similar antibacterial activity when
compared with the compound with the chloride and iodide counterions, a trend that was
not observed for the single-tailed M-1,1,18 (Table 3, Table 4). Once again, no clear trend
relating the Hofmeister series to antibacterial activity of counterion exchanged
compounds was observed, suggesting that other factors may influence changes in
antibacterial activity than colloidal or chemical attributes of Hofmeister series anions
paired with antibacterial amphiphiles.
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Table 4. MIC values of M-1,12,12 paired with four selected Hofmeister series anions (X): bromide,
acetate, chloride, and iodide. Values were confirmed with 2-3 independent experiments. G+ = Grampositive and G- = Gram-negative.
Counterion
(M-1,12,12 + X)

P. aeruginosa
(G-)

E. coli
(G-)

3 Br3 C2H3O23 Cl3 I-

16
4
2
2

8
4
4
8

Minimum Inhibitory Concentration (μM)
E. faecalis S. aureus B. subtilis S. agalactiae
(G+)
(G+)
(G+)
(G+)

4
4
4
2

4
4
4
2

4
4
2
2

B. anthracis
(G+)

8
8
8
2

2
2
2

Previous research has suggested that more chaotropic ions may be more effective
at penetrating lipid monolayers than kosmotropic ions (Zhang and Cremer, 2006), and
may suggest that direct interactions between the ions and the bacterial membrane itself
may be at least partially responsible for the changes in MIC, in addition to interactions
between the counterions and the amphiphiles in solution. Dissolved Hofmeister anions
have also been shown to affect the absorption of cationic polyions onto hydrophobic
surfaces. The addition of more kosmotrophic salts such as NaCl increase electrostatic
screening and allow polycations to move closer to the interface with the hydrophobic
surface. Chaotropic salts such as NaI allow for significant polycationic absorption at low
concentrations, but the amount of polyion absorbed at the hydrophobic interface
decreases with increasing concentrations due to increased electrostatic screening of the
attraction between the anions and the polyelectrolytes (dos Santos and Levin, 2013).
Although these findings were limited to simulation, they support the conclusion that
chaotropic Hofmeister anions such as I- may increase the efficiency of the interaction
between the cationic hydrophilic head residue of these amphiphiles and the lipid
membrane of bacteria. It is also important to note that this does not account for the
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hydrophobic tail residues, which have been shown to have a strong effect on antibacterial
activity. Therefore, it is likely that several aspects of structure contribute to the overall
antibacterial activity of these amphiphiles, and the ideal combination of head group, tail
length, counterion, etc. may differ depending on different attributes of the bacteria such
as membrane structure (Lo Nostro et al. 2005).
Continued research is necessary to fully understand how counterion exchange
affects the antibacterial activity of these amphiphiles. Although a clear trend was not
observed, chloride and iodide may have promise as counterions for future compounds,
especially those intended for use against P. aeruginosa. Further study of these effects is
necessary to fully understanding the mechanisms of this change in antibacterial activity,
as it is possible that counterion exchange with chloride and iodide may influence other
aspects of antibacterial activity, such as biofilm disruption.
3.3 Methods.
Synthesis of M-1,1
Preparation of M-1,1 was completed with a 1:1.8 molar equivalence of 1,3,5Trisbromomeythylbenzene (0.0056mol, 350mL) to trimethylamine (0.01009mol,
150mL) in acetone. Both solutions are chilled on ice for 15min. After chilling, the
trimethylamine solution was added drop wise to the 1,3,5-Trisbromomeythylbenzene
solution overnight, while on ice. The product of the reaction was then filtered and
recrystallized using a 100:3 solution of acetone to ethanol (100mL per 27mg M-1,1).
Synthesis of the product confirmed using 1HNMR.
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Synthesis of M-1,1,18
Preparation of M-1,1,18 was completed using a 1:1.5 mole ratio of M-1,1 to
dimethyl-octadecylamine respectively. The reaction was completed in ethanol and left at
80°C under reflux overnight. The product was dried under N2 gas, re-suspended in
acetone, and filtered. The resulting solid was recrystallized using ethanol and acetone.
Synthesis of the product was confirmed using 1HNMR.
Counterion exchange of M-1,1,18
Monovalent counter ion exchange was done with a 1:3.6 molar equivalence of M1,1,18 to the corresponding AgX salt (X=NO3-, C2H3O2-, I-, and SCN-). While divalent
counter ion exchange was done with a 1:1.8 molar equivalence of M-1,1,18 to the
corresponding Ag2X salt (X=CO32-). The reaction was done in methanol (45mL per
250mg M-1,1,18), stirring overnight under light free conditions. The resulting product
was filtered through a celite packed filter and rinsed with 50 mL of excess methanol. The
filtrate was rotovapped down at temperatures below 50˚C. The resulting solid was
resuspended in 5mL methanol and centrifuged for 3min. A small partition of the
supernatant was combined with AgNO3- and the resulting precipitate was tested on the
PXRD. The absence of major peaks at 31 and 44.3 indicated that no remaining AgBr was
present in solution. The supernatant was then rotovapped down and the resulting solid
was put in the desiccator with P2O5 to remove any water present. The presence of the
correct ion exchanged compound was confirmed via HRMS and 1HNMR.
Critical aggregation concentration
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A conductivity probe was used to measure the critical aggregate concentration of
the amphiphile. The solution was heated to 37°C. The probe was mixed in the solution
and the measurements were collected. Ten percent of the current solution was pipetted
out and replaced with nanopure water. The solution was mixed and the conductivity
measurement recorded. These steps were repeated for the entirety of the experiment.
Bacterial strains and growth conditions
The two Gram-negative bacterial strains used were Escherichia coli ATCC®
25922™ and Pseudomonas aeruginosa ATCC® 27853™, and the five Gram-positive
bacterial strains used in this study were Staphylococcus aureus subsp. aureus ATCC®
29213™, Enterococcus faecalis ATCC® 29212™, Bacillus subtilis, B. anthracis Sterne,
and Streptococcus agalactiae J48 (Seifert et al. 2006). All strains were grown in 1X
Mueller-Hinton Broth at 37° C for 12–24 h. For the MIC studies, bacterial suspensions
were prepared by diluting overnight cultures to 5x106 CFU/mL in 2X Mueller-Hinton
Broth, so that when amphiphile solutions were added the final broth strength was 1X.
Minimum inhibitory concentration
The methods used to determine the MIC were performed as previously described
(Ladow et al. 2011; CLSI, 2012). Briefly, compounds were serially diluted in sterile
dionized water and 100µL of each dilution were added to the wells of a 96-well flatbottomed microtiter plate in triplicate. After adding 100µL of the bacterial cell
suspension (5x106 CFU/mL), the plates were incubated at 37°C for 72 h. The MIC of the
compound was defined as the minimum concentration that resulted in visible inhibition of
bacterial growth.
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Chapter 4: The effect of spacer variation on the antibacterial activity of bis- and
tetra-cationic double-tailed amphiphiles.
4.1 Introduction.
The relative size of the hydrophobic region of QACs relative to the hydrophilic
region is one of the greatest predictors of membrane permeability and antibacterial
activity (Paniak et al. 2014). While changing the length of the hydrocarbon tails alters the
size of the hydrophobic region relative to the charged head group and alter characteristics
of membrane insertion activity, this effect may also be achieved by changing the way the
hydrocarbon tails are positioned on the central ring of the amphiphile. It is therefore
possible that changing the number of carbons separating two symmetrical hydrocarbon
tails on a central Mesitylene ring may affect antibacterial activity.
Three series of bis-cationic amphiphiles and three series of tetra-catioic
amphiphiles were synthesized in order to determine differences in the orientation of the
hydrocarbon tails relative to one another on the central ring affects antibacterial activity.
The bis-cationic amphiphiles included one series with the symmetrical tails in an ortho
orientation (oX-n,n), one series with the tails in a meta orientation (mX-n,n), and one
series with the tails in a para orientation (pX-n,n; Figure 7). The oX-n,n series included
four tail length derivatives ranging from 8 to 14 carbons per tail. The mX-n,n series
included three tail length derivatives ranging from 8 to 12 carbons per tail, and the pXn,n series included five derivatives ranging from 8 to 16 carbons per tail.
Tetra-cationic amphiphiles each had two head groups, each containing two
dimethylammonium residues separated by a chain of two carbons. Each head group had a
single attached hydrocarbon tail. The two tails were symmetrical and varied in length
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from 8-12 carbons for each of the three series: oX-(2,n)2, . mX-(2,n)2, and pX-(2,n)2
(Figure 8).
Additionally, one series of three triple-tailed amphiphiles was also tested for its
antibacterial activity. The M-(2,n)3 series consists of amphiphiles with six positive
charges and three tails, each of varying lengths (Figure 9)
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3.2 Results and Discussion.
The antibacterial activity of the bis-cationic series of amphiphiles followed the same
trend as previous amphiphile series according to tail length, with 12 carbon derivatives
having the lowest MIC values (Table 5, Figure 15). This trend was seen for all three
series, suggesting that, similar to series with changes in head group discussed in Chapter
1, the length of the hydrocarbon tails is the most accurate predictor of antibacterial
activity. Changing the spacer length between the tails on the central ring did not appear to
have a significant effect on which hydrocarbon tail length was most effective.
The 12-carbon derivatives of the bis-cationic series had broad-spectrum
antibacterial activity against both Gram-positive and Gram-negative bacteria.
Interestingly, oX-12,12 had the highest level of bacteriocidal activity against P.
aeruginosa, with an MIC of 2 μM, two- to four-fold lower than that of the Gram-positive
species tested. pX-12,12 had an MIC of 2-4 μM against Gram-positive bacteria, and 4
μM against both P. aeruginosa and E. coli (Table 5).

Table 5. Antibacterial activity of bis-cationic compounds in the oX-n,n, mX-n,n, and pX-n,n series with
different hydrocarbon tail lengths. oX = ortho orientation; mX = meta orientation; pX = para orientation
and n = the number of carbons per tail. G- = Gram-negative and G+ = Gram-positive.

Compound

P. aeruginosa
(G-)

E. coli
(G-)

oX-8,8
oX-10,10
oX-12,12
oX-14,14
mX-8,8
mX-10,10
mX-12,12
pX-8,8
pX-10,10
pX-12,12
pX-14,14
pX-16,16

>250
31
2
31
250
31
8
>250
8
4
31
250

250
16
4
63
>250
16
8
>250
16
4
31
125

Minimum Inhibitory Concentration (μM)
E. faecalis
S. aureus B. subtilis S. agalactiae
(G+)
(G+)
(G+)
(G+)

125
4
8
8
>250
16
8
>250
8
2
16
250

250
16
8
63
>250
16
8
>250
8
2
31

>250
8
4
4
125
16
8
250
8
2
16
31

16
8
16
>250
8
4
250
8
4
4
31

B. anthracis
(G+)

250
16
4
4
125
4
4
250
8
4
8
63
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E. coli (G-)

log [MIC (µM)]

P. aeruginosa (G-)
3

3
2.5
2
1.5
1
0.5
0

2.5
2
1.5
1
0.5
0
8

10

12

14

16

8

log [MIC (µM)]

12

14

16

S. aureus (G+)

E. faecalis (G+)
3

3
2.5
2
1.5
1
0.5
0

2.5
2
1.5
1
0.5
0
8

10

12

14

16

8

10

12

14

3
2.5
2
1.5
1
0.5
0

3
2.5
2
1.5
1
0.5
0
8

10

12

14

16

8

10

12

14

Tail length

B. anthracis (G+)
log [MIC (µM)]

16

S. agalactiae (G+)

B. subtilis (G+)
log [MIC (µM)]

10

3
2.5
2
1.5
1
0.5
0
8

10

12

14

16

Tail length
Figure 15. Antibacterial activity against seven bacterial species of bis-cationic compounds in the oX-n,n
(diamonds), mX-n,n (squares), and pX-n,n (triangles) series with different hydrocarbon tail lengths. G- =
Gram-negative and G+ = Gram-positive.
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Three series of tetra-cationic amphiphiles were also evaluated for their
antibacterial activity (MIC) at three different hydrocarbon tail lengths for three spacer
sizes (ortho, meta, and para orientation). For the compounds with the tails in the meta
and para orientations, the same trend was observed as the bis-cationic amphiphiles
discussed earlier. Compounds with the ideal 12 carbon chain length had the lowest MIC
values compared to other tail lengths in the series. However, for tetra-cationic
amphiphiles with the tails in the ortho orientation relative to one another, 8 hydrocarbons
per tail appeared to be the most effective, with oX-(2,8)2 having the lowest MIC values (4
μM against Gram-negative bacteria, and 2 μM against Gram-positive bacteria) compared
to oX-(2,10)2 and oX-(2,12)2 (Table 6, Figure 16).

Table 6. Antibacterial activity of tetra-cationic compounds in the oX-(2,n)2, mX-(2,n)2, and pX-(2,n)2
series with different hydrocarbon tail lengths. oX = ortho orientation; mX = meta orientation; pX = para
orientation and n = the number of carbons per tail. G- = Gram-negative and G+ = Gram-positive.

Compound

P. aeruginosa
(G-)

E. coli
(G-)

oX-(2,8)2
oX-(2,10)2
oX-(2,12)2
mX-(2,8)2
mX-(2,10)2
mX-(2,12)2
pX-(2,8)2
pX-(2,10)2
pX-(2,12)2

4
125
250
>250
16
8
>250
16
16

4
31
63
>250
16
8
250
16
4

Minimum Inhibitory Concentration (μM)
E. faecalis S. aureus
B. subtilis
S. agalactiae
(G+)
(G+)
(G+)
(G+)

2
16
250
250
16
2
250
16
2

2
16
125
>250
16
2
250
16
2

2
4
250
250
4
4
250
4
4

2
2
125
>250
4
4
>250
4
4

B. anthracis
(G+)

2
4
250
125
4
4
125
4
4
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log [MIC (µM)]

P. aeruginosa (G-)

E. coli (G-)

3

3

2.5

2.5

2

2

1.5

1.5

1

1

0.5

0.5

0

0
8

10

12

8

10

S. aureus (G+)

log [MIC (µM)]

E. faecalis (G+)
3

3
2.5
2
1.5
1
0.5
0

2.5
2
1.5
1
0.5
0
8

10

12

8

10

B. subtilis (G+)
log [MIC (µM)]

12

S. agalactiae (G+)

3

3
2.5
2
1.5
1
0.5
0

2.5
2
1.5
1
0.5
0
8

10

12

8

10

12

Tail length

B. anthracis (G+)
log [MIC (µM)]

12

3
2.5
2
1.5
1
0.5
0
8

10

12

Tail length
Figure 16. Antibacterial activity against seven bacterial species of tetra-cationic compounds in the oX(2,n)2 (diamonds), mX-(2,n)2 (squares), and pX-(2,n)2 (triangles) series with different hydrocarbon tail
lengths. G- = Gram-negative and G+ = Gram-positive.
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A single triple-tailed series, M-(2,n)3, was also tested for its antibacterial activity.
This series of compounds contains six positive charges and three tails of equal length,
each with 8, 10, or 12 carbons. The compound with 10 carbons per tail (M-[2,10]3) had
the lowest MIC values of any of the three derivatives (Table 7. Figure 17). Similar to the
trend observed for the tetra-cationic oX-(2,n)2 series, the ideal tail length for the M-(2,n)3
series was not 12 carbons, as it was for the majority of the other compounds tested. The
8-carbon and 12-carbon tail length derivatives of this series both had higher MIC values
on the whole than the 10-carbon derivative.

Table 7. Antibacterial activity of the triple-tailed M-(2,n)3 series. n = the number of carbons per tail. G- =
Gram-negative and G+ = Gram-positive.
Compound
M-(2,n)3

P. aeruginosa
(G-)

E. coli
(G-)

M-(2,8)3
M-(2,10)3
M-(2,12)3

16
8
16

16
2
31

Minimum Inhibitory Concentration (μM)
E. faecalis S. aureus
B. subtilis S. agalactiae
(G+)
(G+)
(G+)
(G+)

16
2
2

1
1
4

4
1
8

4
4
4

1.6

log(MIC [μM])

1.4
P. aeruginosa (G-)

1.2

E. coli (G-)

1
0.8

E. faecalis (G+)

0.6

S. aureus (G+)

0.4

B. subtilis (G+)

0.2

S. agalactiae (G+)

0
8

10

12

B. anthracis (G+)

Tail length (n for M-[2,n]2)
Figure 17. Antibacterial activity of compounds in the M-(2,n)3 series with different
hydrocarbon tail lengths. G- = Gram-negative and G+ = Gram-positive.

B. anthracis
(G+)

2
1
4
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The MIC of M-(2,10)3 was notably as low as 1 μM against several Gram-positive
species, including S. aureus, and was as low as 2 μM against the Gram-negative E. coli
and 8 μM against P. aeruginosa (Table 7). These MIC values are comparable to the MIC
values of 12-carbon derivatives of the double-tailed, triscationic series studied previously.
These data taken together suggest that the ideal length of the hydrocarbon tails of
these amphiphiles may change depending on other structural characteristics. Changes in
the distribution of charge within the head group of these molecules likely affect
electrostatic interactions between the amphiphiles and the largely negative lipid
membrane of bacteria. Because electrostatic interactions and hydrophobic interactions
both contribute to the overall antimicrobial mechanism of action (Ramos et al. 2007),
changing the distribution of charge in relation to the size of the hydrophobic region may
have significant effects on the ability of these molecules to insert into the membrane.
Because the oX-(2,n)2 series has four positive residues compared to two in the oX-(n,n)
series, this effect may be more pronounced, resulting in the change in the ideal size of the
hydrophobic tails for insertion into the bacterial membrane.
3.3 Methods.
Bacterial strains and growth conditions.
The two Gram-negative bacterial strains used were Escherichia coli ATCC®
25922™ and Pseudomonas aeruginosa ATCC® 27853™, and the five Gram-positive
bacterial strains used in this study were Staphylococcus aureus subsp. aureus ATCC®
29213™, Enterococcus faecalis ATCC® 29212™, Bacillus subtilis, B. anthracis Sterne,
and Streptococcus agalactiae J48 (Seifert et al. 2006). All strains were grown in 1x
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Mueller-Hinton Broth at 37° C for 12–24 h. For the MIC studies, bacterial suspensions
were prepared by diluting overnight cultures to 5x106 CFU/mL in 2X Mueller-Hinton
Broth, so that when amphiphile solutions were added the final broth strength was1X.
Minimum inhibitory concentration.
The methods used to determine the MIC were performed as previously described
(Ladow et al. 2011; CLSI, 2012). Briefly, compounds were serially diluted in sterile
dionized water and 100µL of each dilution were added to the wells of a 96-well flatbottomed microtiter plate in triplicate. After adding 100µL of the bacterial cell
suspension (5x106 CFU/mL), the plates were incubated at 37°C for 72 h. The MIC of the
compound was defined as the minimum concentration that resulted in visible inhibition of
bacterial growth.
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Chapter 5: Conclusions and Future Research.
5.1 Conclusions
The minimum inhibitory concentration was determined for all amphiphiles
against two Gram-negative and five Gram-positive organisms. Tail length affects
antibacterial activity, with one tail length being optimal for each series. Consistent with
previous studies (Marafino et al. 2015), compounds with twelve carbons in each of two
symmetrical hydrocarbon tails are the most effective, compared to compounds with
longer or shorter tails. This trend was observed for four different amphiphile series, each
with a differently substituted third head group residue, suggesting that head group
substitution does not have as large of an effect on antibacterial activity as tail length,
provided that the head group residues are of comparable size and charge.
All of the amphiphiles tested (M-E,12,12; M-DMAP,12,12; M-IQ,1212; and M4PP,12,12) were capable of disrupting established biofilm. Despite having MIC values as
low as 4-8 µM, significant biofilm disruption was only observed at much higher
concentrations, approximately 31-63 µM. This was unsurprising, considering the fact that
bacteria in biofilms tend to be highly resistant to antibiotics and biocides (Lewis, 2001).
M-E,12,12; M-DMAP,12,12; and M-IQ,12,12 were able to disrupt a similar amount of
established P. aeruginosa biofilm as the antibiotic tobramycin at comparable
concentrations. The amphiphile M-4PP,12,12 disrupted a similar amount of biofilm as
benzalkonium chloride at comparable concentrations, though the amount of biofilm
removed by M-4PP,12,12 was lower than that removed by the other 12-carbon derivative
compounds tested. Due to their ability to remove established biofilms, these compounds
may have potential to be used as novel disinfectants, especially in combination with other
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antimicrobial agents. Further research is necessary to determine the exact mechanism of
action of biofilm removal, and what aspects of amphiphile structure are most important
for variations in anti-biofilm activity.
Different counterions also affect antibacterial activity. Substitution of bromide
with different ions from the Hofmeister series led to changes in MIC, particularly against
P. aeruginosa. The single-tailed amphiphile M-1,1,18 and the double-tailed amphiphile
M-1,12,12 were more effective at inhibiting the growth of P. aeruginosa with chloride
and iodide counterions than with bromide. Other counterions such as acetate, carbonate,
and nitrate had little effect, or even increased the MIC for these amphiphiles. Despite
notable differences in the MIC for amphiphiles paired with different Hofmeister
counterions, no clear trend was observed between the MIC and any chemical attributes of
the Hofmeister series itself. Although use of different counterions such as chloride and
iodide appear to have potential to increase the efficacy of charged cationic antimicrobials,
particularly against Gram-negative pathogens such as P. aeruginosa, more research is
needed to determine the mechanism by which these different counterions increase the
efficacy of quaternary ammonium amphiphiles.
Finally, the orientation of tails relative to each other on the mesitylene core of
tetra-cationic amphiphiles also has an effect on the optimal tail length. The amphiphiles
with tails in the para or meta orientation on the central ring followed a similar trend to
the tris-cationic double-tailed amphiphiles, with 12 carbons being the ideal length per tail
for the most efficient antibacterial activity. However, amphiphiles with the two tails in
the ortho orientation on the central ring had an optimal tail length of 8 carbons per tail.
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No shift in the optimal tail length was observed for the bis-cationic amphiphiles.
Bis-cationic amphiphiles with the two tails in the ortho, meta, and para orientation, all
had an ideal tail length of 12 carbons per tail.
The shift in optimal tail length specific to tetra-cationic amphiphiles bears further
study, particularly the possibility that compounds in the oX-(2,n)2 series with shorter
hydrocarbon tails may have even more efficient antibacterial activity. If 8 carbons is
indeed the ideal tail length for amphiphiles in this series, then it is more likely that the
MIC will increase with shorter tail lengths, similar to the trend observed for previously
tested compounds, whose ideal tail length is 12 carbons per tail.
All of these data can be used to synthesize more effective compounds in the
future. Understanding effects of tail length, counterion, and charge distribution on
antibacterial activity, biofilm disruption, and cytotoxicity will be useful for developing
amphiphilic compounds that may serve as novel antibiotics or disinfectants. The
development of novel compounds is essential to prevent the spread of resistant infections
in the population, particularly in people with compromised immune systems, such as the
elderly or those with chronic diseases, and especially in hospitals.
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5.2 Future Reseach
10-14-AO – Fluorescent Compound
The fluorescent compound 10-14-AO was derived from acridine orange. A 50 μM
solution of 10-14-AO was incubated at room temperature for one hour with an overnight
liquid culture of Streptococcus agalactiae and visualized using a 60X objective on a
confocal microscope.
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Figure 18. Excitation and emission
spectra for 10-14-AO. Excitation
was determined by irradiating the
sample with light from 400-520 nm
and monitoring emitted light at 531
nm. Emission was determined by
irradiating the sample with light at
493 nm and monitoring emitted
light from 500-750 nm.
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The compound 10-14-AO was
successfully taken up into the bacterial cells
and fluoresced at approximately 540 nm,
allowing for the visualization of intact S.
agalactiae cells (Figure 18, Figure 19). This
compound may have applications in the
determination of mechanism of action, or in
the study of the movement of amphiphiles
through bacterial biofilm over time. The

Figure 19. S. agalactiae incubated with
fluorescent compound 10-14-AO, visualized
at 60X magnification using confocal
microscopy.
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antibacterial activity of this compound has yet to be determined, and further studies will
determine the effects of structural changes on fluorescence and uptake into the cells, as
well as biofilm penetration.
Activity against other E.S.K.A.P.E. pathogens
E.S.K.A.P.E. pathogens refer to the most relevant antibiotic-resistant bacteria
(Enterococcus faecium, S. aureus, Klebsiella pneumoniae, Acinetobacteri baumanii, P.
aeruginosa, and Enterobacter species; Rice, 2008). Because of their promising level of
activity against prominent pathogens such as P. aeruginosa and S. aureus, these
amphiphiles should be tested for their ability to kill other as-yet-untested pathogenic
bacteria such as Acinetobacter baumannii and Klebsiella pneumoniae. While these
pathogens pose little risk to healthy people, they are common causes of healthcareassociated wound and bloodstream infection, and are often resistant to many commonly
used antibiotics (CDC, 2010; 2015). K. pneumoniae, in particular, has been implicated in
the increasing spread of carbapenem-resistant Enterobacteriaceae (CRE) due to its ability
to produce a potent carbapenemase (CDC, 2015). Due to their broad spectrum of activity
against Gram-negative and Gram-positive pathogens notorious for having high levels of
resistance to antibacterial compounds, the compounds presented in this study may also be
effective against K. pneumoniae and A. baumannii, presenting an opportunity for the
development of new compounds to prevent the spread of these and other prominent
opportunistic pathogens.
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Mechanism of action
Given ample previous research into the mechanism of action of amphiphilc AMPs
and structurally similar amphiphiles, it is likely that these compounds are membraneactive, causing depolarization and lysis of bacterial cells (Dathe and Wieprecht, 1999;
Thiyagarajan et al. 2014; Goswami et al. 2015). Propidium iodide permeability assays
can be used in order to gain more information about the membrane-permeabilizing
activity of these compounds (Rieger et al. 2011). Further studies to determine the biofilm
disruption mechanism will be explored such as fluorescence microscopy.
Cytotoxicity
Because the mode of action of these compounds is likely membrane
permeabilization, depolarization and lysis, it is possible that these amphiphiles may not
be compatible with human cells. The cytotoxicity of amphiphiles is largely structuredependent, with some amphiphiles having cytotoxic concentrations many times higher
than the MIC (Goswami et al. 2015). It is also possible that fundamental differences
between the mammalian and bacterial cell membranes may increase the therapeutic
potential of these compounds. Namely, unlike the net negatively charged bacterial
membrane, the outer leaflet of the mammalian plasma membrane is neutral, with
negatively charged phospholipids largely localized to the cytosolic leaflet (Cooper,
2000). This may decrease the effects of electrostatic interactions between cationic
membrane-active compounds and the membrane by making hydrophobic interactions the
largest driving force behind insertion into the membrane. Determination of cytoxicity
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through hemolysis assays and testing using epithelial cells is necessary to confirm the
safety of these compounds for therapeutic use.
Synergistic combinations and pre-treatment
Synergistic combinations of some similar amphiphiles have been observed in
prior studies (Marafino et al. 2015). Of particular interest is the potential for synergy
between antibacterial amphiphiles and sodium metaperiodate (NaIO4), which is used to
disrupt extracellular polysaccharides, particularly against established biofilms (Gawande
et al. 2007; Gutiérrez et al. 2013). Since these compounds likely disrupt bacterial biofilms
by infiltrating the matrix and lysing cells within the biofilm, without disrupting the matrix
itself directly, pre-treatment or co-incubation with NaIO4 may increase the biofilm
disruption ability of QACs.
Some research also suggests that synergistic interactions with conventional
antibiotics may increase bactericidal activity. Membrane permeabilizing agents have been
used with antibiotics such as erythromycin in order to make Gram-negative bacteria
susceptible to otherwise ineffective treatments by breaking down their outer membrane
(Goswami et al. 2015). Similar studies to characterize any synergistic combinations of
these compounds and a variety of antibiotics could further characterize the method of
action of the compounds being studied, as well as provide a proof of concept for these
compounds being used as adjuvants in treatment with conventional antibiotics.
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